| scholarly article | Q13442814 |
| P50 | author | Chad M. Rienstra | Q18631653 |
| Stephanie A. Smith | Q46924869 | ||
| James H Morrissey | Q57024638 | ||
| P2093 | author name string | Sharon H Choi | |
| Jillian Huyck | |||
| John Boettcher | |||
| Rebecca Davis-Harrison | |||
| P2860 | cites work | Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo | Q24655664 |
| Inorganic polyphosphate: a molecule of many functions | Q28139415 | ||
| Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis | Q28508572 | ||
| Culture medium for enterobacteria | Q29616466 | ||
| Inorganic polyphosphate stimulates mammalian TOR, a kinase involved in the proliferation of mammary cancer cells | Q30449939 | ||
| Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation | Q30479254 | ||
| Metabolism and function of polyphosphates in bacteria and yeast. | Q33711958 | ||
| Polyphosphate as a general procoagulant agent | Q33724794 | ||
| Polyphosphate modulates blood coagulation and fibrinolysis. | Q34304738 | ||
| Human platelet dense granules contain polyphosphate and are similar to acidocalcisomes of bacteria and unicellular eukaryotes. | Q34340830 | ||
| Polyphosphate enhances fibrin clot structure | Q36915892 | ||
| The plasma kallikrein-kinin system: its evolution from contact activation | Q36947203 | ||
| Preparative and analytical purification of DNA from agarose | Q37313673 | ||
| Novel assay reveals multiple pathways regulating stress-induced accumulations of inorganic polyphosphate in Escherichia coli. | Q39565323 | ||
| Inorganic polyphosphate and specific induction of apoptosis in human plasma cells | Q40234907 | ||
| Purification and characterization of polyphosphate kinase from Neisseria meningitidis. | Q40268560 | ||
| Anti-HIV-1 activity of inorganic polyphosphates | Q41130385 | ||
| Polyphosphate blocks tumour metastasis via anti-angiogenic activity | Q42155924 | ||
| Induction of calcification in MC3T3-E1 cells by inorganic polyphosphate | Q42826999 | ||
| Inorganic polyphosphate in mammalian cells and tissues | Q42829243 | ||
| Secretion, subcellular localization and metabolic status of inorganic pyrophosphate in human platelets. A major constituent of the amine-storing granules | Q42881956 | ||
| Isolation of a high molecular weight polyphosphate from Neisseria gonorrhoeae | Q42936528 | ||
| Sensitive fluorescence detection of polyphosphate in polyacrylamide gels using 4',6-diamidino-2-phenylindol. | Q50464995 | ||
| Improved procedures for the determination of lipid phosphorus by malachite green | Q67927798 | ||
| Preparation of standards and determination of sizes of long-chain polyphosphates by gel electrophoresis | Q69010810 | ||
| Physiological concentrations of tissue factor pathway inhibitor do not inhibit prothrombinase | Q71087670 | ||
| Distinctive regulation of contact activation by antithrombin and C1-inhibitor on activated platelets and material surfaces | Q84589400 | ||
| P433 | issue | 20 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4353-4359 | |
| P577 | publication date | 2010-08-13 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Polyphosphate exerts differential effects on blood clotting, depending on polymer size | |
| P478 | volume | 116 |
| Q35637441 | 2013 scientific sessions Sol Sherry distinguished lecture in thrombosis: polyphosphate: a novel modulator of hemostasis and thrombosis. |
| Q91723687 | A Stringent Analysis of Polyphosphate Dynamics in Escherichia coli |
| Q38798595 | A flow cytometry-based assay for procoagulant platelet polyphosphate |
| Q53676932 | A highly selective fluorescent sensor for Al³⁺ and the use of the resulting complex as a secondary sensor for PPi in aqueous media: its applicability in live cell imaging. |
| Q39228502 | A kinetic method for expeditious detection of pyrophosphate anions at nanomolar concentrations based on a nucleic acid fluorescent sensor |
| Q55260308 | Ability of Polyphosphate and Nucleic Acids to Trigger Blood Clotting: Some Observations and Caveats. |
| Q92541956 | Accumulation of Nucleolar Inorganic Polyphosphate Is a Cellular Response to Cisplatin-Induced Apoptosis |
| Q37903933 | Advances in our understanding of the molecular basis of disorders of platelet function |
| Q35920828 | Allosteric inhibition of factor XIa. Sulfated non-saccharide glycosaminoglycan mimetics as promising anticoagulants |
| Q38543315 | Antithrombotic therapy for ventricular assist devices in children: do we really know what to do? |
| Q35561296 | Arterial thrombosis is accelerated in mice deficient in histidine-rich glycoprotein |
| Q38234314 | Bacteria under stress by complement and coagulation. |
| Q98394626 | Bacterial polyphosphates interfere with the innate host defense to infection |
| Q39683706 | Blocking inhibition of prothrombinase by tissue factor pathway inhibitor alpha: a procoagulant property of heparins |
| Q47304447 | Bone-targeting poly(ethylene sodium phosphate). |
| Q38845465 | Clotting activity of polyphosphate-functionalized silica nanoparticles. |
| Q27027361 | Complement-Coagulation Cross-Talk: A Potential Mediator of the Physiological Activation of Complement by Low pH |
| Q36144212 | Comprehensive study into the activation of the plasma enzyme systems during attacks of hereditary angioedema due to C1-inhibitor deficiency |
| Q64958113 | DNA ladders can be used to size polyphosphate resolved by polyacrylamide gel electrophoresis. |
| Q92756618 | Damage- and pathogen-associated molecular patterns play differential roles in late mortality after critical illness |
| Q35153224 | Defective PDI release from platelets and endothelial cells impairs thrombus formation in Hermansky-Pudlak syndrome |
| Q39117235 | Differential Roles for the Coagulation Factors XI and XII in Regulating the Physical Biology of Fibrin. |
| Q42725749 | Dynamics of Thrombin Generation and Flux from Clots during Whole Human Blood Flow over Collagen/Tissue Factor Surfaces |
| Q90738977 | Electrostatic Complementarity Drives Amyloid/Nucleic Acid Co-Assembly |
| Q38138876 | Emerging paradigms in arterial thrombosis |
| Q36253998 | Exacerbated venous thromboembolism in mice carrying a protein S K196E mutation |
| Q36387981 | Extracellular chromatin is an important mediator of ischemic stroke in mice |
| Q35172492 | Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4 |
| Q36070475 | FXIa and platelet polyphosphate as therapeutic targets during human blood clotting on collagen/tissue factor surfaces under flow |
| Q27024190 | Factor XI and contact activation as targets for antithrombotic therapy |
| Q37398521 | Factor XI anion-binding sites are required for productive interactions with polyphosphate. |
| Q57824341 | Factor XII Activation Promotes Platelet Consumption in the Presence of Bacterial-Type Long-Chain Polyphosphate In Vitro and In Vivo |
| Q47644061 | Factor XII and uPAR upregulate neutrophil functions to influence wound healing |
| Q37022061 | Factor XII promotes blood coagulation independent of factor XI in the presence of long-chain polyphosphates. |
| Q41665262 | Factor XII-Driven Inflammatory Reactions with Implications for Anaphylaxis |
| Q38587540 | Factor XII: a novel target for safe prevention of thrombosis and inflammation |
| Q38860396 | Factor XII: form determines function |
| Q89036008 | From underlying chemistry to therapeutic potential: open questions in the new field of lysine polyphosphorylation |
| Q38168784 | Hemostatic strategies for traumatic and surgical bleeding |
| Q43714467 | High-molecular-weight kininogen and the risk of a myocardial infarction and ischemic stroke in young women: the RATIO case-control study |
| Q37388786 | Histone H4 promotes prothrombin autoactivation |
| Q36783613 | How it all starts: Initiation of the clotting cascade. |
| Q47126929 | Immunohaemostasis: a new view on haemostasis during sepsis |
| Q66829436 | Importance of polyphosphate in the Leishmania life cycle |
| Q36010211 | Inhibition of factor XI activation attenuates inflammation and coagulopathy while improving the survival of mouse polymicrobial sepsis |
| Q36509624 | Inhibition of polyphosphate as a novel strategy for preventing thrombosis and inflammation |
| Q93051676 | Inorganic polyphosphate, a multifunctional polyanionic protein scaffold |
| Q39031470 | Inorganic polyphosphate: a key modulator of inflammation |
| Q90480697 | Integrating platelet and coagulation activation in fibrin clot formation |
| Q42011864 | Localization of Short-Chain Polyphosphate Enhances its Ability to Clot Flowing Blood Plasma. |
| Q97520716 | Mechanisms and biomarkers of cancer-associated thrombosis |
| Q58327024 | Monitoring pyrophosphate anions via cobalt(ii)-modulated fluorescence of cadmium sulfide quantum dots |
| Q37261059 | Neutralizing blood-borne polyphosphate in vivo provides safe thromboprotection |
| Q36068279 | New insights into the mechanisms of venous thrombosis |
| Q55652396 | New players in haemostasis and thrombosis. |
| Q34551176 | Nontoxic polyphosphate inhibitors reduce thrombosis while sparing hemostasis. |
| Q27680138 | Novel Family of Insect Salivary Inhibitors Blocks Contact Pathway Activation by Binding to Polyphosphate, Heparin, and Dextran Sulfate |
| Q36167707 | Nucleic acid scavengers inhibit thrombosis without increasing bleeding. |
| Q51785583 | One-pot synthesis of highly greenish-yellow fluorescent nitrogen-doped graphene quantum dots for pyrophosphate sensing via competitive coordination with Eu(3+) ions. |
| Q34980897 | Ongoing contact activation in patients with hereditary angioedema |
| Q34293215 | Phosphoramidate end labeling of inorganic polyphosphates: facile manipulation of polyphosphate for investigating and modulating its biological activities |
| Q35092465 | Platelet surface-associated activation and secretion-mediated inhibition of coagulation factor XII. |
| Q36169665 | Platelet-Derived Short-Chain Polyphosphates Enhance the Inactivation of Tissue Factor Pathway Inhibitor by Activated Coagulation Factor XI. |
| Q26820857 | Platelet-based coagulation: different populations, different functions |
| Q41235836 | PolyP's many faces |
| Q53721304 | Polyphosphate accelerates factor V activation by factor XIa. |
| Q48122836 | Polyphosphate and RNA Differentially Modulate the Contact Pathway of Blood Clotting. |
| Q64118859 | Polyphosphate as a Target for Interference With Inflammation and Thrombosis |
| Q35835056 | Polyphosphate as modulator of hemostasis, thrombosis, and inflammation |
| Q39330912 | Polyphosphate colocalizes with factor XII on platelet-bound fibrin and augments its plasminogen activator activity |
| Q30834726 | Polyphosphate delays fibrin polymerisation and alters the mechanical properties of the fibrin network |
| Q36003987 | Polyphosphate elicits pro-inflammatory responses that are counteracted by activated protein C in both cellular and animal models |
| Q41877238 | Polyphosphate in Neonates: Less Shedding from Platelets and Divergent Prothrombotic Capacity Due to Lower TFPI Levels |
| Q35631344 | Polyphosphate is a cofactor for the activation of factor XI by thrombin |
| Q41663740 | Polyphosphate is a novel cofactor for regulation of complement by a serpin, C1 inhibitor. |
| Q36217204 | Polyphosphate is a novel pro-inflammatory regulator of mast cells and is located in acidocalcisomes |
| Q28307913 | Polyphosphate is a primordial chaperone |
| Q41323819 | Polyphosphate multi-tasks |
| Q48098873 | Polyphosphate nanoparticles on the platelet surface trigger contact system activation |
| Q37535268 | Polyphosphate suppresses complement via the terminal pathway |
| Q92670224 | Polyphosphate, Zn2+ and high molecular weight kininogen modulate individual reactions of the contact pathway of blood clotting |
| Q35619579 | Polyphosphate, platelets, and coagulation |
| Q89776759 | Polyphosphate/platelet factor 4 complexes can mediate heparin-independent platelet activation in heparin-induced thrombocytopenia |
| Q35991866 | Polyphosphate: a link between platelets, coagulation and inflammation |
| Q35556300 | Polyphosphate: a new player in the field of hemostasis |
| Q26865798 | Polyphosphate: an ancient molecule that links platelets, coagulation, and inflammation |
| Q64076152 | Polyphosphates and Complement Activation |
| Q35171206 | Protein quality control under oxidative stress conditions |
| Q50961053 | Proteolytic properties of single-chain factor XII: a mechanism for triggering contact activation. |
| Q37233988 | Restoring the procofactor state of factor Va-like variants by complementation with B-domain peptides |
| Q26828498 | Role of β-hydroxybutyrate, its polymer poly-β-hydroxybutyrate and inorganic polyphosphate in mammalian health and disease |
| Q90050662 | Roles of Factor XII in Innate Immunity |
| Q48114290 | Silica particles contribute to the procoagulant activity of DNA and polyphosphate isolated using commercial kits. |
| Q48651455 | Single-chain factor XII exhibits activity when complexed to polyphosphate |
| Q39366435 | Single-chain factor XII: a new form of activated factor XII. |
| Q47404980 | Size matters for polyP to clot |
| Q34033754 | Synthesis and evaluation of chromogenic and fluorogenic substrates for high-throughput detection of enzymes that hydrolyze inorganic polyphosphate. |
| Q28559769 | Synthetic polyphosphate inhibits endogenous coagulation and platelet aggregation in vitro |
| Q89765217 | TFPIα interacts with FVa and FXa to inhibit prothrombinase during the initiation of coagulation |
| Q92083332 | The Reduced Level of Inorganic Polyphosphate Mobilizes Antioxidant and Manganese-Resistance Systems in Saccharomyces cerevisiae |
| Q36833564 | The dimeric structure of factor XI and zymogen activation |
| Q37066587 | The emerging role of coagulation proteases in kidney disease |
| Q38795041 | The initiation and effects of plasma contact activation: an overview |
| Q37853060 | The many faces of the contact pathway and their role in thrombosis |
| Q36051099 | The polyphosphate-factor XII pathway drives coagulation in prostate cancer-associated thrombosis |
| Q38840361 | The polyphosphate/factor XII pathway in cancer-associated thrombosis: novel perspectives for safe anticoagulation in patients with malignancies. |
| Q37276726 | Tissue factor pathway inhibitor-alpha inhibits prothrombinase during the initiation of blood coagulation |
| Q37971520 | Tissue factor pathway inhibitor: structure-function |
| Q50115928 | Translational Implications of Platelets as Vascular First Responders |
| Q38248477 | Why does aspirin decrease the risk of venous thromboembolism? On old and novel antithrombotic effects of acetyl salicylic acid |
Search more.